CRISIL.NS
CRISIL Limited [CRISIL.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CRISIL.NS Stock Summary
In the News
CRISIL.NS Financial details
Company Rating
Strong Buy
Market Cap
354.11B
Income
6.58B
Revenue
31.4B
Book val./share
299.43
Cash/share
157
Dividend
49
Dividend %
1.19%
Employees
4.67K
Optionable
No
Shortable
Yes
Earnings
16 Apr 2024
P/E
49.5
Forward P/E
-
PEG
29.92
P/S
9.86
P/B
15.59
P/C
29.59
P/FCF
-
Quick Ratio
0.79
Current Ratio
1.99
Debt / Equity
0.02
LT Debt / Equity
0.01
-
-
EPS (TTM)
90.1
EPS next Y
-
EPS next Q
-
EPS this Y
16.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
13.6%
Revenue last 5Y
12.64%
Revenue Q/Q
24.71%
EPS Q/Q
38.17%
-
-
-
-
SMA20
-2.92%
SMA50
19.98%
SMA100
13.86%
Inst Own
-
Inst Trans
-
ROA
21%
ROE
33%
ROC
0.39%
Gross Margin
49%
Oper. Margin
26%
Profit Margin
20%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3241.1-5268.5
52W High
-11.81%
52W Low
+43.35%
RSI
37.62
Rel Volume
0.19
Avg Volume
59.01K
Volume
11.37K
Perf Week
-5.09%
Perf Month
-5.21%
Perf Quarter
18.25%
Perf Half Y
19.66%
-
-
-
-
Beta
0.413
-
-
Volatility
92.18%, 112.48%
Prev Close
-0.74%
Price
4646
Change
-4.3%
CRISIL.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 239.71 | 273.38 | 316.24 | 379.24 | 429.52 | |
| Net income per share | 47.61 | 48.93 | 64.03 | 77.31 | 90.08 | |
| Operating cash flow per share | 61.72 | 69.04 | 55.41 | 62.51 | 107.91 | |
| Free cash flow per share | 57.69 | 64.22 | 52.28 | 56.87 | 99.3 | |
| Cash per share | 82.5 | 80.5 | 102.21 | 111.31 | 157.04 | |
| Book value per share | 162.22 | 180.95 | 216.96 | 245.46 | 299.51 | |
| Tangible book value per share | 117.15 | 108.4 | 148.38 | 177.16 | 222.11 | |
| Share holders equity per share | 162.22 | 180.95 | 216.96 | 245.46 | 299.51 | |
| Interest debt per share | 0.4 | 32.9 | 19.39 | 12.31 | 6.97 | |
| Market cap | 137.81B | 139.3B | 209.85B | 223.93B | 312.16B | |
| Enterprise value | 134.42B | 138.79B | 208.27B | 221.57B | 308.93B | |
| P/E ratio | 40.07 | 39.27 | 45.05 | 39.68 | 47.41 | |
| Price to sales ratio | 7.96 | 7.03 | 9.12 | 8.09 | 9.94 | |
| POCF ratio | 30.91 | 27.83 | 52.06 | 49.07 | 39.57 | |
| PFCF ratio | 33.06 | 29.92 | 55.17 | 53.93 | 43.01 | |
| P/B Ratio | 11.76 | 10.62 | 13.29 | 12.5 | 14.26 | |
| PTB ratio | 11.76 | 10.62 | 13.29 | 12.5 | 14.26 | |
| EV to sales | 7.76 | 7 | 9.05 | 8 | 9.84 | |
| Enterprise value over EBITDA | 26.12 | 23.77 | 31.31 | 26.57 | 34.98 | |
| EV to operating cash flow | 30.15 | 27.73 | 51.66 | 48.55 | 39.17 | |
| EV to free cash flow | 32.25 | 29.81 | 54.76 | 53.37 | 42.56 | |
| Earnings yield | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | |
| Free cash flow yield | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
| Debt to equity | 0 | 0.17 | 0.08 | 0.05 | 0.02 | |
| Debt to assets | 0 | 0.1 | 0.05 | 0.03 | 0.01 | |
| Net debt to EBITDA | -0.66 | -0.09 | -0.24 | -0.28 | -0.37 | |
| Current ratio | 1.95 | 1.57 | 1.79 | 1.87 | 2.08 | |
| Interest coverage | 2.08K | 32.17 | 62.63 | 114.16 | 212.92 | |
| Income quality | 0.91 | 1.09 | 0.65 | 0.61 | 1.2 | |
| Dividend Yield | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | |
| Payout ratio | 0.73 | 0.65 | 0.59 | 0.61 | 0.54 | |
| Sales general and administrative to revenue | 0.06 | 0.06 | 0.06 | 0.05 | 0.04 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.19 | 0.24 | 0.2 | 0.18 | 0.17 | |
| Capex to operating cash flow | -0.07 | -0.07 | -0.06 | -0.09 | -0.08 | |
| Capex to revenue | -0.02 | -0.02 | -0.01 | -0.01 | -0.02 | |
| Capex to depreciation | -0.79 | -0.29 | -0.22 | -0.4 | -0.61 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 416.86 | 446.35 | 559.08 | 653.41 | 779.14 | |
| ROIC | 0.28 | 0.2 | 0.23 | 0.28 | 0.26 | |
| Return on tangible assets | 0.25 | 0.21 | 0.23 | 0.24 | 0.24 | |
| Graham Net | 26.65 | -16.99 | 7.02 | 19.29 | 74.24 | |
| Working capital | 4.71B | 3.96B | 6.32B | 8.17B | 10.9B | |
| Tangible asset value | 8.46B | 7.86B | 10.79B | 12.93B | 16.24B | |
| Net current asset value | 4.48B | 1.9B | 5.08B | 7.22B | 9.72B | |
| Invested capital | 0 | 0.17 | 0.08 | 0.05 | 0.02 | |
| Average receivables | 1.6B | 3.87B | 5.32B | 7.14B | 7.56B | |
| Average payables | 701.15M | 904.1M | 1.2B | 1.39B | 1.43B | |
| Average inventory | -1.26B | -2.79B | -3.78B | -4.71B | -2.46B | |
| Days sales outstanding | 67.28 | 83.73 | 96.8 | 107.84 | 80.61 | |
| Days payables outstanding | 34.98 | 39.85 | 42.02 | 37.76 | 24.48 | |
| Days of inventory on hand | -116.92 | -115.63 | -141.25 | -129.27 | 0 | |
| Receivables turnover | 5.43 | 4.36 | 3.77 | 3.38 | 4.53 | |
| Payables turnover | 10.44 | 9.16 | 8.69 | 9.67 | 14.91 | |
| Inventory turnover | -3.12 | -3.16 | -2.58 | -2.82 | 0 | |
| ROE | 0.29 | 0.27 | 0.3 | 0.31 | 0.3 | |
| Capex per share | -4.02 | -4.82 | -3.13 | -5.64 | -8.61 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 112.55 | 97.84 | 105.53 | 100.72 | 125.52 | |
| Net income per share | 21.63 | 19.95 | 20.61 | 20.8 | 28.74 | |
| Operating cash flow per share | 7.18 | 7.12 | 7.14 | 7.25 | 6.9 | |
| Free cash flow per share | 7.18 | 7.12 | 7.14 | 7.25 | 6.9 | |
| Cash per share | 111.24 | 111.19 | 99.14 | 94.12 | 157 | |
| Book value per share | 245.29 | 245.26 | 263.48 | 263.48 | 299.43 | |
| Tangible book value per share | 177.04 | 0 | 189.39 | 0 | 222.05 | |
| Share holders equity per share | 245.29 | 245.26 | 263.48 | 263.48 | 299.43 | |
| Interest debt per share | 11.61 | 0.16 | 7.6 | 0.11 | 6.58 | |
| Market cap | 224.08B | 235.16B | 285.17B | 286.71B | 312.24B | |
| Enterprise value | 221.73B | 243.29B | 283.8B | 293.59B | 309.02B | |
| P/E ratio | 35.45 | 40.34 | 47.34 | 47.16 | 37.15 | |
| Price to sales ratio | 27.25 | 32.9 | 36.99 | 38.96 | 34.02 | |
| POCF ratio | 427.32 | 452.24 | 546.92 | 540.97 | 619.28 | |
| PFCF ratio | 427.32 | 452.24 | 546.92 | 540.97 | 619.28 | |
| P/B Ratio | 12.5 | 13.12 | 14.81 | 14.89 | 14.26 | |
| PTB ratio | 12.5 | 13.12 | 14.81 | 14.89 | 14.26 | |
| EV to sales | 26.97 | 34.03 | 36.81 | 39.9 | 33.67 | |
| Enterprise value over EBITDA | 102.47 | 110.18 | 127.89 | 128.98 | 113.12 | |
| EV to operating cash flow | 422.82 | 467.86 | 544.3 | 553.95 | 612.89 | |
| EV to free cash flow | 422.82 | 467.86 | 544.3 | 553.95 | 612.89 | |
| Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0.05 | 0 | 0.03 | 0 | 0.02 | |
| Debt to assets | 0.03 | 0 | 0.02 | 0 | 0.01 | |
| Net debt to EBITDA | -1.09 | 3.68 | -0.62 | 3.02 | -1.18 | |
| Current ratio | 1.87 | 0 | 1.99 | 0 | 2.08 | |
| Interest coverage | 140.87 | 165.09 | 222.53 | 245.28 | 317.9 | |
| Income quality | 0.33 | 0.36 | 0.35 | 0.35 | 0.24 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.06 | 0.05 | 0.04 | 0.04 | 0.04 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.18 | 0 | 0.19 | 0 | 0.17 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 345.51 | 331.79 | 349.54 | 351.17 | 440.02 | |
| ROIC | 0.07 | 0.08 | 0.07 | 0.08 | 0.08 | |
| Return on tangible assets | 0.07 | 0 | 0.06 | 0 | 0.08 | |
| Graham Net | 49.33 | 111.19 | 53.79 | 94.12 | 74.22 | |
| Working capital | 8.17B | 8.12B | 9.05B | 6.88B | 10.9B | |
| Tangible asset value | 12.93B | 0 | 13.84B | 0 | 16.24B | |
| Net current asset value | 7.22B | 8.12B | 8.22B | 6.88B | 9.72B | |
| Invested capital | 0.05 | 0 | 0.03 | 0 | 0.02 | |
| Average receivables | 3.79B | 3.79B | 4.45B | 4.45B | 3.47B | |
| Average payables | 719.6M | 719.6M | 670.05M | 670.05M | 712.8M | |
| Average inventory | 176.55M | 176.55M | 0.5 | 0.5 | 0 | |
| Days sales outstanding | 83.05 | 0 | 103.95 | 0 | 68 | |
| Days payables outstanding | 46.24 | 0 | 27.74 | 0 | 21.38 | |
| Days of inventory on hand | 11.35 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 1.08 | 0 | 0.87 | 0 | 1.32 | |
| Payables turnover | 1.95 | 0 | 3.24 | 0 | 4.21 | |
| Inventory turnover | 7.93 | 0 | 4.35B | 0 | 0 | |
| ROE | 0.09 | 0.08 | 0.08 | 0.08 | 0.1 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
CRISIL.NS Frequently Asked Questions
What is CRISIL Limited stock symbol ?
CRISIL Limited is a IN stock and trading under the symbol CRISIL.NS
What is CRISIL Limited stock quote today ?
CRISIL Limited stock price is $4646 today.
Is CRISIL Limited stock public?
Yes, CRISIL Limited is a publicly traded company.
Company Profile
- Volume Average 59.01K
- Market Capitalization 354.11B
- Employee 4.67K
- CEO Mr. Amish P. Mehta
- Headquarters Mumbai,IN
- IPO Date 2002-07-01
-
Website
https://www.crisil.com 
CRISIL Limited, an analytical company, together with its subsidiaries, provides ratings, data, research, and analytics and solutions in India, Europe, North America, and internationally. It operates through three segments: Ratings, Research, and Advisory. The Ratings services segment offers credit ratings for corporates, banks, bank loans, and small and medium enterprises; credit analysis services; grading services; and analytical services. The Research segment provides research and risk solutions, industry reports, customized research assignments, subscription to data services, independent equity research, initial public offering grading, and training services. The Advisory segment offers advisory services; and a range of risk management tools, analytics, and solutions to financial institutions, banks, and corporates. The company was formerly known as The Credit Rating Information Services of India Limited and changed its name to CRISIL Limited in December 2003. CRISIL Limited was incorporated in 1987 and is headquartered in Mumbai, India.
